Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A O Turkes

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Toplum Ve Bilim|August 18, 2009
[The power of the rural!]A O Turkes
Progress in Medicinal Chemistry|January 1, 1989
Endocrine treatment of prostate cancerA O Turkes, K Griffiths
Journal of Steroid Biochemistry|January 1, 1987
Treatment of patients with advanced cancer of the prostate: phase III trial, zoladex against castration; a study of the British Prostate GroupA O Turkes, W B Peeling, K Griffiths
American Journal of Clinical Oncology|January 1, 1988
Comparison of prostate-specific antigen and prostatic acid phosphatase in the management of prostatic cancerA Turkes, J Nott, A O Turkes, et al.
Journal of Steroid Biochemistry|February 1, 1986
Gas chromatography-mass spectrometric analysis of salivary testosterone with reference to diethylstilboestrol-treated prostatic cancer patientsV J Gould, A O Turkes, S J Gaskell
Steroids|January 1, 1980
A sensitive enzymeimmunoassay with a fluorimetric end-point for the determination of testosterone in female plasma and salivaA O Turkes, A Turkes, B G Joyce, et al.
Steroids|March 1, 1979
A sensitive solid phase enzymeimmunoassay for testosterone in plasma and salivaA Turkes, A O Turkes, B G Joyce, et al.
Lancet (London, England)|August 20, 1983
Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinomaK J Walker, R I Nicholson, A O Turkes, et al.
Progress in Clinical and Biological Research|January 1, 1985
Endocrine factors in the treatment of prostatic cancerC G Pierrepoint, A O Turkes, K J Walker, et al.
The Journal of Endocrinology|November 1, 1984
Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex)K J Walker, A O Turkes, A Turkes, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Toplum Ve Bilim|August 18, 2009
[The power of the rural!]A O Turkes
Progress in Medicinal Chemistry|January 1, 1989
Endocrine treatment of prostate cancerA O Turkes, K Griffiths
Journal of Steroid Biochemistry|January 1, 1987
Treatment of patients with advanced cancer of the prostate: phase III trial, zoladex against castration; a study of the British Prostate GroupA O Turkes, W B Peeling, K Griffiths
American Journal of Clinical Oncology|January 1, 1988
Comparison of prostate-specific antigen and prostatic acid phosphatase in the management of prostatic cancerA Turkes, J Nott, A O Turkes, et al.
Journal of Steroid Biochemistry|February 1, 1986
Gas chromatography-mass spectrometric analysis of salivary testosterone with reference to diethylstilboestrol-treated prostatic cancer patientsV J Gould, A O Turkes, S J Gaskell
Steroids|January 1, 1980
A sensitive enzymeimmunoassay with a fluorimetric end-point for the determination of testosterone in female plasma and salivaA O Turkes, A Turkes, B G Joyce, et al.
Steroids|March 1, 1979
A sensitive solid phase enzymeimmunoassay for testosterone in plasma and salivaA Turkes, A O Turkes, B G Joyce, et al.
Lancet (London, England)|August 20, 1983
Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinomaK J Walker, R I Nicholson, A O Turkes, et al.
Progress in Clinical and Biological Research|January 1, 1985
Endocrine factors in the treatment of prostatic cancerC G Pierrepoint, A O Turkes, K J Walker, et al.
The Journal of Endocrinology|November 1, 1984
Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex)K J Walker, A O Turkes, A Turkes, et al.
Pageof 2